Live Breaking News & Updates on Carolina Urologic Research|Page 2

Stay updated with breaking news from Carolina urologic research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Neal Shore joins Clarity's Clinical Advisory Board

/PRNewswire/ Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the. ....

New South Wales , Alan Taylor , Bladder Cancer Advocacy Network , Duke Global Health Institute , Guidelines Committee For Bladder Cancer , Prnewswire Clarity Pharmaceuticals , Clarity Pharmaceuticals , Carolina Urologic Research Centre , American College Of Surgeons , Education Committee , Clinical Advisory Board , Chief Medical Officer , Surgical Oncology , Medical Director , Carolina Urologic Research , Executive Chairman , New York Hospital Cornell Medical , Memorial Sloan Kettering Cancer , Bladder Cancer , Duke Global Health , Urology Times , Eurology Practice , World Journal , American College , Neal Shore , Targeted Copper Theranostic ,

Black/African American prostate cancer patients treated with darolutamide show outcomes similar to the overall population

Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had clinical outcomes similar to those observed in the overall clinical trial population, according to results from the ARAMIS phase III clinical trial presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021. ....

United States , Astellas Pharma , Orion Pharma , Bristol Myers Squibb Sanofi , Bristol Myers Squibb , Medivation Astellas , Emily Henderson , Foundation Medicine , Bayer Ag , Ferring Pharmaceuticals , Myovant Sciences , Carolina Urologic Research Center , Boston Scientific , Janssen Scientific Affairs , Tolmar Inc , African American , Cancer Health Disparities , Ethnic Minorities , Medically Underserved , Medical Director , Carolina Urologic Research , Bristol Myers , Clovis Oncology , Exact Imaging , Myriad Genetics , Propella Therapeutics ,

Darolutamide Showed similar benefits for Black/African American patients as observed

PHILADELPHIA – Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had ....

United States , Astellas Pharma , Orion Pharma , Bristol Myers Squibb Sanofi , Bristol Myers Squibb , Medivation Astellas , Foundation Medicine , Bayer Ag , Myovant Sciences , Carolina Urologic Research Center , Ferring Pharmaceuticals , Boston Scientific , Eastern Cooperative Oncology Group , Janssen Scientific Affairs , Tolmar Inc , African American , Cancer Health Disparities , Ethnic Minorities , Medically Underserved , Neal Shore , Carolina Urologic Research , Bristol Myers , Clovis Oncology , Exact Imaging , Myriad Genetics , Propella Therapeutics ,

Prostate Cancer Screenings on the Decline with Concerns Surrounding COVID-19: What Men Should Know

Sponsored Story
By StoryStudio April 1, 2021 4:35 pm
(BPT) – In the early part of the COVID-19 pandemic, many areas of the country banned nonessential medical procedures in an effort to slow the spread of the disease. As a result, many physicians saw fewer patients for routine medical care, such as physical exams and screenings. A recent survey by The Physicians Foundation polled 3,513 physicians and found 41% saw volume decreases of 26% or more in their practices.
The impact on cancer screenings was even more profound. For example, screenings for prostate cancer one of the most commonly diagnosed cancers in men in the United States dropped by 56% by the peak of the pandemic in April according to a recent study published in ....

United States , American Society Of Clinical Oncology , National Cancer Institute , America Physicians , Carolina Urologic Research Center , Drug Administration , National Cancer Institute Surveillance , End Results Program , Physicians Foundation , American Cancer Society , Neal Shore , Medical Director , Carolina Urologic Research , Posterior Reversible Encephalopathy Syndrome , Important Safety Information , Reversible Encephalopathy Syndrome , Patient Information , Full Prescribing Information , Cancer Inform , Prostate Cancer , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , தேசிய புற்றுநோய் நிறுவனம் , அமெரிக்கா மருத்துவர்கள் , கரோலினா சிறுநீரக ஆராய்ச்சி மையம் , தேசிய புற்றுநோய் நிறுவனம் கண்காணிப்பு ,

Prostate Cancer Screenings on the Decline with Concerns Surrounding COVID-19: What Men Should Know

Posted
Monday,
February 22, 2021
10:01 am
(BPT) - In the early part of the COVID-19 pandemic, many areas of the country banned nonessential medical procedures in an effort to slow the spread of the disease. As a result, many physicians saw fewer patients for routine medical care, such as physical exams and screenings. A recent survey by The Physicians Foundation polled 3,513 physicians and found 41% saw volume decreases of 26% or more in their practices.
The impact on cancer screenings was even more profound. For example, screenings for prostate cancer one of the most commonly diagnosed cancers in men in the United States dropped by 56% by the peak of the pandemic in April according to a recent study published in ....

United States , National Cancer Institute Surveillance , End Results Program , Physicians Foundation , Carolina Urologic Research Center , Drug Administration , American Cancer Society , Neal Shore , Medical Director , Carolina Urologic Research , National Cancer Institute , Posterior Reversible Encephalopathy Syndrome , Important Safety Information , Reversible Encephalopathy Syndrome , ஒன்றுபட்டது மாநிலங்களில் , தேசிய புற்றுநோய் நிறுவனம் கண்காணிப்பு , முடிவு முடிவுகள் ப்ரோக்ர்யாம் , மருத்துவர்கள் அடித்தளம் , கரோலினா சிறுநீரக ஆராய்ச்சி மையம் , அமெரிக்கன் புற்றுநோய் சமூகம் , நீல் கரை , மருத்துவ இயக்குனர் , கரோலினா சிறுநீரக ஆராய்ச்சி , தேசிய புற்றுநோய் நிறுவனம் , முக்கியமான பாதுகாப்பு தகவல் ,